По вашему запросу найдено документов: 201

Страница 9 из 21

СПОСОБ ВЫБОРА БЕЗОПАСНОГО МЕТОДА ХОЛЕЦИСТЭКТОМИИ
METHOD OF SELECTING SAFE METHOD OF CHOLECYSTECTOMY
ТИМЕРБУЛАТОВ, Ш.В., ТИМЕРБУЛАТОВ, В.М., САРГСЯН, А.М., СИБАЕВ, В.М., Timerbulatov, Sh.V., Timerbulatov, V.M., Sargsyan, A.M., Sibaev, V.M. (2019)
РИСК-АДАПТИРОВАННАЯ ТЕРАПИЯ МИЕЛОДИСПЛАСТИЧЕСКИХ СИНДРОМОВ
RISK-ADAPTED THERAPY OF MYELODYSPLASTIC SYNDROMES
Г. А. Дудина, G. A. Dudina, С. В. Семочкин, S. V. Semochkin, Б. А. Бакиров, B. A. Bakirov (Медицинский вестник Башкортостана, №2, 2018)
СПОСОБ ПРОГНОЗИРОВАНИЯ ВЫЖИВАЕМОСТИ БОЛЬНЫХ С ИШЕМИЧЕСКИМ ИНСУЛЬТОМ, АССОЦИИРОВАННЫМ С COVID-19
METHOD FOR PREDICTION OF SURVIVAL OF PATIENTS WITH ISCHEMIC STROKE ASSOCIATED WITH COVID-19
НОВИКОВА, Л.Б., ЛАТЫПОВА, Р.Ф., Novikova, L.B., Latypova, R.F. (2023)
СПОСОБ ПРОГНОЗИРОВАНИЯ СТЕПЕНИ РИСКА ФОРМИРОВАНИЯ ПРОЛАПСА ТАЗОВЫХ ОРГАНОВ У ЖЕНЩИН
METHOD FOR PREDICTING THE DEGREE OF RISK OF PELVIC ORGAN PROLAPSE FORMATION IN WOMEN
ЗИГАНШИН, А.М., САЛИМОНЕНКО, Д.А., ШАЙХИЕВА, Э.А., МУДРОВ, В.А., КАТАЕВА, Р.М., МУХАМЕТДИНОВА, И.Г., ZIGANSHIN, A.M., SALIMONENKO, D.A., SHAJKHIEVA, E.A., MUDROV, V.A., KATAEVA, R.M., MUKHAMETDINOVA, I.G. (2022)
Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
Bo, C., Zhang, H., Cao, Y., Lu, X., Zhang, C., Li, S., Kong, X., Zhang, X., Bai, M., Tian, K., Saitgareeva, A., Lyaysan, G., Wang, J., Ning, S., Wang, L. (2021)
RNA–miRNA). Then, 3/4/5-node regulatory motifs were detected in the TMGN. Then, the motifs with the highest Z-score
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Coignard, J., Lush, M., Beesley, J., O’Mara, T.A., Dennis, J, Tyrer, J.P., Barnes, D.R., McGuffog, L., Leslie, G., Bolla, M.K., Adank, M.A., Kiiski, J.I., Nevanlinna, H., team of authors (2021)
towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))
Coignard, J., Lush, M., Beesley, J., Andrieu, N., Antoniou, A.C., Fabienne Lesueur, Noura Mebirouk, Nadine Andrieu, Joe Dennis, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, Daniel Barrowdale, Debra Frost, Paul D. P. Pharoah, Qin Wang, Douglas F. Easton, Antonis C. Antoniou, Irene L. Andrulis, Hoda Anton-Culver, Argyrios Ziogas, Jacques Simard, Volker Arndt, Hermann Brenner, Norbert Arnold, Jacopo Azzollini, Siranoush Manoukian, Bermisheva, Marina, Khusnutdinova, Elza, Blomqvist, Carl, Białkowska, Katarzyna, Jakubowska, Anna (2021)
towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
-binding peptide 3 showed a dose-dependent increase during MOD-4023 treatment. IGF-I standard deviation score
A RANDOMIZED PHASE 2 STUDY OF LONG-ACTING TRANSCON GH VS DAILY GH IN CHILDHOOD GH DEFICIENCY
Chatelain, Pierre, Malievskiy, Oleg, Radziuk, Klaudziya, Senatorova, Ganna, Abdou, Magdy O., Vlachopapadopoulou, Elpis, Skorodok, Yulia, Peterkova, Valentina, Leff, Jonathan A., Beckert, Michael (2017)
, with IGF-1 standard deviation scores increasing into the normal range for all three TransCon GH doses
AVPR1A MAIN EFFECT AND OXTR-BY-ENVIRONMENT INTERPLAY IN INDIVIDUAL DIFFERENCES IN DEPRESSION LEVEL
KAZANTSEVA, A.V., DAVYDOVA, YU.D., ENIKEEVA, R.F., LOBASKOVA, M.M., MUSTAFIN, R.N., MALYKH, S.B., TAKHIROVA, Z.R., KHUSNUTDINOVA, E.K. (2020)
young adults from Russia. Methods: Depression score was assessed using Beck Depression Inventory (BDI

Страница 9 из 21

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год